Latest Update: Impact of current COVID-19 situation has been considered in this report while making the analysis.
Global Montelukast Sodium Market by Type (Montelukast Sodium Amorphous, Montelukast Sodium Crystalline), By Application (Tablets, Chewable Tablet, Oral Solution) And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030-report

Global Montelukast Sodium Market by Type (Montelukast Sodium Amorphous, Montelukast Sodium Crystalline), By Application (Tablets, Chewable Tablet, Oral Solution) And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030

Report ID: 143664 3300 Chemical & Material 377 248 Pages 4.9 (35)
                                          

Market Overview:


The global montelukast sodium market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in the market can be attributed to factors such as rising prevalence of asthma and allergic rhinitis, increasing awareness about asthma and its treatment, and growing demand for montelukast sodium in emerging markets. However, patent expiry of certain blockbuster drugs is expected to restrain the growth of the market during the forecast period. On the basis of type, montelukast sodium amorphous accounted for a major share of the global montelukast sodium market in 2017. This segment is projected to grow at a CAGR of 5.8% during the forecast period from 2018 to 2030 due to its high efficacy and better patient compliance as compared with other types available in the market. On account on application, tablets accounted for a major share fo th eglobalmont eluka st so dium m arket i n2017 .Thi s segm ent i s proj ected t o gr ow ataC AG Rof5 .


Global Montelukast Sodium Industry Outlook


Product Definition:


Montelukast Sodium is a leukotriene receptor antagonist used for the prevention and long-term treatment of asthma and chronic obstructive pulmonary disease (COPD).


Montelukast Sodium Amorphous:


Montelukast sodium amorphous is a prescription drug that belongs to the group of drugs called leukotriene receptor antagonists. Montelukast sodium amorphous has no real active ingredients in it, instead it has molecules of salt and Morphine which mimic the action of leukotrienes.


Montelukast Sodium Crystalline:


It is a white crystalline powder derived from the fermentation of Montelukast. It has a molecular weight of 464.5 and is soluble in water, ethanol, and diethyl ether but not in chloroform or carbon tetrachloride. The product has an odor similar to that of yeast or cheese and it's taste can be described as neutral with no particular flavor noted.


The chemical was developed by Cipla Inc.


Application Insights:


On the basis of application, the global market has been segmented into tablets, chewable tablet, and oral solution. The tablets were estimated to be the largest revenue-generating segment in 2017. This is attributed to high product usage in asthma treatment as compared to other applications.


The oral solution was estimated to be the fastest-growing application segment over the forecast period owing to increasing product use as an anti-asthma medication for treating milder forms of asthmatic conditions in children below 12 years of age. Montelukast sodium is approved by FDA for use in patients younger than 2 years old; however, it is generally prescribed for older children and adults with asthma due largely on its longer half life and lower dosage requirements when compared with that seen in pediatric patients above 2 years of age (U.S).


Regional Analysis:


North America dominated the global market in 2017. This can be attributed to the higher incidence of asthma and rhinitis among all age groups in this region as compared to other regions. The U.S., which is one of the most developed countries, still records high cases of asthma and rhinitis among children that require treatment with anti-inflammatory drugs, which further increases product demand during winters.


Asia Pacific is expected to witness significant growth over the forecast period owing to increasing disposable income levels coupled with rising consumer awareness regarding available treatments for allergic disorders such as Montelukast sodium amorphous tablets, chewable tablet & oral solution (tetrahydrozoline). These factors are also expected to contribute toward increased demand for products over the forecast period from 2018 through 2030  ending up in a lucrative revenue share by 2030  ending up with North America being a major shareholder followed by Europe and Asia Pacific respectively.


Growth Factors:


  • Increasing prevalence of asthma and other respiratory diseases: The global Montelukast Sodium market is expected to grow at a CAGR of 5.5% during the forecast period owing to the increasing prevalence of asthma and other respiratory diseases.
  • Growing awareness about the benefits of Montelukast Sodium: There is a growing awareness among people about the benefits of Montelukast Sodium, which is expected to drive market growth during the forecast period.
  • Rising demand for combination therapies: The demand for combination therapies is rising due to their better efficacy as compared to single-drug therapies, which is expected to boost market growth during the forecast period.
  • Technological advancements in Montelukast Sodium delivery systems: There has been a significant advancement in technology that has led to development of novel delivery systems for Montelukast Sodium, such as orally disintegrating tablets (ODTs), nasal sprays, and chewable tablets, which are anticipated to fuel market growth during the forecast period.

Scope Of The Report

Report Attributes

Report Details

Report Title

Montelukast Sodium Market Research Report

By Type

Montelukast Sodium Amorphous, Montelukast Sodium Crystalline

By Application

Tablets, Chewable Tablet, Oral Solution

By Companies

Morepen Laboratories, Mylan, TAPI, MSN Laboratories, Ultratech India, Aurobindo Pharma, Hetero Labs, Unimark Remedies, Jubilant Cadista, Aamorb Pharmaceuticals, Sudarshan Groups, Ortin Laboratories, Vamsi Labs, Adley Group, Medopharm, Hengyuan Pharmaceutical, Arromax Pharmaceutical Technology, Lihe Wuhan New Chemical Materials, Shanghai Huachu Chemical

Regions Covered

North America, Europe, APAC, Latin America, MEA

Base Year

2021

Historical Year

2019 to 2020 (Data from 2010 can be provided as per availability)

Forecast Year

2030

Number of Pages

248

Number of Tables & Figures

174

Customization Available

Yes, the report can be customized as per your need.


Global Montelukast Sodium Market Report Segments:

The global Montelukast Sodium market is segmented on the basis of:

Types

Montelukast Sodium Amorphous, Montelukast Sodium Crystalline

The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.

Applications

Tablets, Chewable Tablet, Oral Solution

The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.

Some of the companies that are profiled in this report are:

  1. Morepen Laboratories
  2. Mylan
  3. TAPI
  4. MSN Laboratories
  5. Ultratech India
  6. Aurobindo Pharma
  7. Hetero Labs
  8. Unimark Remedies
  9. Jubilant Cadista
  10. Aamorb Pharmaceuticals
  11. Sudarshan Groups
  12. Ortin Laboratories
  13. Vamsi Labs
  14. Adley Group
  15. Medopharm
  16. Hengyuan Pharmaceutical
  17. Arromax Pharmaceutical Technology
  18. Lihe Wuhan New Chemical Materials
  19. Shanghai Huachu Chemical

Global Montelukast Sodium Market Overview


Highlights of The Montelukast Sodium Market Report:

  1. The market structure and projections for the coming years.
  2. Drivers, restraints, opportunities, and current trends of market.
  3. Historical data and forecast.
  4. Estimations for the forecast period 2030.
  5. Developments and trends in the market.
  6. By Type:

    1. Montelukast Sodium Amorphous
    2. Montelukast Sodium Crystalline
  1. By Application:

    1. Tablets
    2. Chewable Tablet
    3. Oral Solution
  1. Market scenario by region, sub-region, and country.
  2. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
  3. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
  4. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Montelukast Sodium Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.

Regional Analysis

  • North America
  • Europe
  • Asia Pacific
  • Middle East & Africa
  • Latin America

Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.

The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.

How you may use our products:

  • Correctly Positioning New Products
  • Market Entry Strategies
  • Business Expansion Strategies
  • Consumer Insights
  • Understanding Competition Scenario
  • Product & Brand Management
  • Channel & Customer Management
  • Identifying Appropriate Advertising Appeals

Global Montelukast Sodium Market Statistics

8 Reasons to Buy This Report

  1. Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
  2. Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
  3. Implemented Robust Methodology to Prepare the Report
  4. Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
  5. Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
  6. Provides Information About the Top-winning Strategies Implemented by Industry Players.
  7. In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
  8. Customization of the Report Available

Frequently Asked Questions?


Montelukast sodium is a medication used to treat asthma. It works by reducing the inflammation and swelling in the airways.

Some of the major companies in the montelukast sodium market are Morepen Laboratories, Mylan, TAPI, MSN Laboratories, Ultratech India, Aurobindo Pharma, Hetero Labs, Unimark Remedies, Jubilant Cadista, Aamorb Pharmaceuticals, Sudarshan Groups, Ortin Laboratories, Vamsi Labs, Adley Group, Medopharm, Hengyuan Pharmaceutical, Arromax Pharmaceutical Technology, Lihe Wuhan New Chemical Materials, Shanghai Huachu Chemical.

The montelukast sodium market is expected to register a CAGR of 5.5%.

                                            
1. Executive Summary

2. Assumptions and Acronyms Used

3. Research Methodology

4. Montelukast Sodium Market Overview
   4.1. Introduction
      4.1.1. Market Taxonomy
      4.1.2. Market Definition
   4.2. Macro-Economic Factors
      4.2.1. Industry Outlook
   4.3. Montelukast Sodium Market Dynamics
      4.3.1. Market Drivers
      4.3.2. Market Restraints
      4.3.3. Opportunity
      4.3.4. Market Trends
   4.4. Montelukast Sodium Market - Supply Chain
   4.5. Global Montelukast Sodium Market Forecast
      4.5.1. Montelukast Sodium Market Size (US$ Mn) and Y-o-Y Growth
      4.5.2. Montelukast Sodium Market Size (000’ Units) and Y-o-Y Growth
      4.5.3. Montelukast Sodium Market Absolute $ Opportunity

5. Global Montelukast Sodium Market Analysis and Forecast by Type
   5.1. Market Trends
   5.2. Introduction
      5.2.1. Basis Point Share (BPS) Analysis by Type
      5.2.2. Y-o-Y Growth Projections by Type
   5.3. Montelukast Sodium Market Size and Volume Forecast by Type
      5.3.1. Montelukast Sodium Amorphous
      5.3.2. Montelukast Sodium Crystalline
   5.4. Absolute $ Opportunity Assessment by Type
   5.5. Market Attractiveness/Growth Potential Analysis by Type

6. Global Montelukast Sodium Market Analysis and Forecast by Application
   6.1. Market Trends
   6.2. Introduction
      6.2.1. Basis Point Share (BPS) Analysis by Application
      6.2.2. Y-o-Y Growth Projections by Application
   6.3. Montelukast Sodium Market Size and Volume Forecast by Application
      6.3.1. Tablets
      6.3.2. Chewable Tablet
      6.3.3. Oral Solution
   6.4. Absolute $ Opportunity Assessment by Application
   6.5. Market Attractiveness/Growth Potential Analysis by Application

7. Global Montelukast Sodium Market Analysis and Forecast by Sales Channel
   7.1. Market Trends
   7.2. Introduction
      7.2.1. Basis Point Share (BPS) Analysis by Sales Channel 
      7.2.2. Y-o-Y Growth Projections by Sales Channel
   7.3. Montelukast Sodium Market Size and Volume Forecast by Sales Channel 
      7.3.1. Manufacturer/Distributor/Service Provider
      7.3.2. Aftermarket
   7.4. Absolute $ Opportunity Assessment by Sales Channel
   7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel

8. Global Montelukast Sodium Market Analysis and Forecast by Region
   8.1. Market Trends
   8.2. Introduction
      8.2.1. Basis Point Share (BPS) Analysis by Region
      8.2.2. Y-o-Y Growth Projections by Region
   8.3. Montelukast Sodium Market Size and Volume Forecast by Region
      8.3.1. North America
      8.3.2. Latin America
      8.3.3. Europe
      8.3.4. Asia Pacific
      8.3.5. Middle East and Africa (MEA)
   8.4. Absolute $ Opportunity Assessment by Region
   8.5. Market Attractiveness/Growth Potential Analysis by Region
   8.6. Global Montelukast Sodium Demand Share Forecast, 2019-2026

9. North America Montelukast Sodium Market Analysis and Forecast
   9.1. Introduction
      9.1.1. Basis Point Share (BPS) Analysis by Country
      9.1.2. Y-o-Y Growth Projections by Country
   9.2. North America Montelukast Sodium Market Size and Volume Forecast by Country
      9.2.1. U.S.
      9.2.2. Canada
   9.3. Absolute $ Opportunity Assessment by Country
   9.4. North America Montelukast Sodium Market Size and Volume Forecast by Application
      9.4.1. Tablets
      9.4.2. Chewable Tablet
      9.4.3. Oral Solution
   9.5. Basis Point Share (BPS) Analysis by Application
   9.6. Y-o-Y Growth Projections by Application
   9.7. North America Montelukast Sodium Market Size and Volume Forecast by Type
      9.7.1. Montelukast Sodium Amorphous
      9.7.2. Montelukast Sodium Crystalline
   9.8. Basis Point Share (BPS) Analysis by Type
   9.9. Y-o-Y Growth Projections by Type
   9.10. Market Attractiveness/Growth Potential Analysis
      9.10.1. By Country
      9.10.2. By Product Type
      9.10.3. By Application
      9.10.4. By Sales Channel
   9.11. North America Montelukast Sodium Demand Share Forecast, 2019-2026

10. Latin America Montelukast Sodium Market Analysis and Forecast
   10.1. Introduction
      10.1.1. Basis Point Share (BPS) Analysis by Country
      10.1.2. Y-o-Y Growth Projections by Country
      10.1.3. Latin America Average Pricing Analysis
   10.2. Latin America Montelukast Sodium Market Size and Volume Forecast by Country
      10.2.1. Brazil
      10.2.2. Mexico
      10.2.3. Rest of Latin America
   10.3. Absolute $ Opportunity Assessment by Country
   10.4. Latin America Montelukast Sodium Market Size and Volume Forecast by Application
      10.4.1. Tablets
      10.4.2. Chewable Tablet
      10.4.3. Oral Solution
   10.5. Basis Point Share (BPS) Analysis by Application
   10.6. Y-o-Y Growth Projections by Application
   10.7. Latin America Montelukast Sodium Market Size and Volume Forecast by Type
      10.7.1. Montelukast Sodium Amorphous
      10.7.2. Montelukast Sodium Crystalline
   10.8. Basis Point Share (BPS) Analysis by Type
   10.9. Y-o-Y Growth Projections by Type
   10.10. Market Attractiveness/Growth Potential Analysis
      10.10.1. By Country
      10.10.2. By Product Type
      10.10.3. By Application
      10.10.4. By Sales Channel
   10.11. Latin America Montelukast Sodium Demand Share Forecast, 2019-2026

11. Europe Montelukast Sodium Market Analysis and Forecast
   11.1. Introduction
      11.1.1. Basis Point Share (BPS) Analysis by Country
      11.1.2. Y-o-Y Growth Projections by Country
      11.1.3. Europe Average Pricing Analysis
   11.2. Europe Montelukast Sodium Market Size and Volume Forecast by Country
      11.2.1. Germany
      11.2.2. France
      11.2.3. Italy
      11.2.4. U.K.
      11.2.5. Spain
      11.2.6. Russia
      11.2.7. Rest of Europe
   11.3. Absolute $ Opportunity Assessment by Country
   11.4. Europe Montelukast Sodium Market Size and Volume Forecast by Application
      11.4.1. Tablets
      11.4.2. Chewable Tablet
      11.4.3. Oral Solution
   11.5. Basis Point Share (BPS) Analysis by Application
   11.6. Y-o-Y Growth Projections by Application
   11.7. Europe Montelukast Sodium Market Size and Volume Forecast by Type
      11.7.1. Montelukast Sodium Amorphous
      11.7.2. Montelukast Sodium Crystalline
   11.8. Basis Point Share (BPS) Analysis by Type
   11.9. Y-o-Y Growth Projections by Type
   11.10. Market Attractiveness/Growth Potential Analysis
      11.10.1. By Country
      11.10.2. By Product Type
      11.10.3. By Application
      11.10.4. By Sales Channel
   11.11. Europe Montelukast Sodium Demand Share, 2019-2026

12. Asia Pacific Montelukast Sodium Market Analysis and Forecast
   12.1. Introduction
      12.1.1. Basis Point Share (BPS) Analysis by Country
      12.1.2. Y-o-Y Growth Projections by Country
      12.1.3. Asia Pacific Average Pricing Analysis
   12.2. Asia Pacific Montelukast Sodium Market Size and Volume Forecast by Country
      12.2.1. China
      12.2.2. Japan
      12.2.3. South Korea
      12.2.4. India
      12.2.5. Australia
      12.2.6. Rest of Asia Pacific (APAC)
   12.3. Absolute $ Opportunity Assessment by Country
   12.4. Asia Pacific Montelukast Sodium Market Size and Volume Forecast by Application
      12.4.1. Tablets
      12.4.2. Chewable Tablet
      12.4.3. Oral Solution
   12.5. Basis Point Share (BPS) Analysis by Application
   12.6. Y-o-Y Growth Projections by Application
   12.7. Asia Pacific Montelukast Sodium Market Size and Volume Forecast by Type
      12.7.1. Montelukast Sodium Amorphous
      12.7.2. Montelukast Sodium Crystalline
   12.8. Basis Point Share (BPS) Analysis by Type
   12.9. Y-o-Y Growth Projections by Type
   12.10. Market Attractiveness/Growth Potential Analysis
      12.10.1. By Country
      12.10.2. By Product Type
      12.10.3. By Application
      12.10.4. By Sales Channel
   12.11. Asia Pacific Montelukast Sodium Demand Share, 2019-2026

13. Middle East & Africa Montelukast Sodium Market Analysis and Forecast
   13.1. Introduction
      13.1.1. Basis Point Share (BPS) Analysis by Country
      13.1.2. Y-o-Y Growth Projections by Country
      13.1.3. Asia Pacific Average Pricing Analysis
   13.2. Middle East & Africa Montelukast Sodium Market Size and Volume Forecast by Country
      13.2.1. Saudi Arabia
      13.2.2. South Africa
      13.2.3. UAE
      13.2.4. Rest of Middle East & Africa (MEA)
   13.3. Absolute $ Opportunity Assessment by Country
   13.4. Middle East & Africa Montelukast Sodium Market Size and Volume Forecast by Application
      13.4.1. Tablets
      13.4.2. Chewable Tablet
      13.4.3. Oral Solution
   13.5. Basis Point Share (BPS) Analysis by Application
   13.6. Y-o-Y Growth Projections by Application
   13.7. Middle East & Africa Montelukast Sodium Market Size and Volume Forecast by Type
      13.7.1. Montelukast Sodium Amorphous
      13.7.2. Montelukast Sodium Crystalline
   13.8. Basis Point Share (BPS) Analysis by Type
   13.9. Y-o-Y Growth Projections by Type
   13.10. Market Attractiveness/Growth Potential Analysis
      13.10.1. By Country
      13.10.2. By Product Type
      13.10.3. By Application
      13.10.4. By Sales Channel
   13.11. Middle East & Africa Montelukast Sodium Demand Share, 2019-2026

14. Competition Landscape
   14.1. Global Montelukast Sodium Market: Market Share Analysis
   14.2. Montelukast Sodium Distributors and Customers
   14.3. Montelukast Sodium Market: Competitive Dashboard
   14.4. Company Profiles (Details – Overview, Financials, Developments, Strategy) 
      14.4.1. Morepen Laboratories
         14.4.1.1. Overview
         14.4.1.2. Financials
         14.4.1.3. Developments
         14.4.1.4. Strategic Outlook
      14.4.2. Mylan
         14.4.2.1. Overview
         14.4.2.2. Financials
         14.4.2.3. Developments
         14.4.2.4. Strategic Outlook
      14.4.3. TAPI
         14.4.3.1. Overview
         14.4.3.2. Financials
         14.4.3.3. Developments
         14.4.3.4. Strategic Outlook
      14.4.4. MSN Laboratories
         14.4.4.1. Overview
         14.4.4.2. Financials
         14.4.4.3. Developments
         14.4.4.4. Strategic Outlook
      14.4.5. Ultratech India
         14.4.5.1. Overview
         14.4.5.2. Financials
         14.4.5.3. Developments
         14.4.5.4. Strategic Outlook
      14.4.6. Aurobindo Pharma
         14.4.6.1. Overview
         14.4.6.2. Financials
         14.4.6.3. Developments
         14.4.6.4. Strategic Outlook
      14.4.7. Hetero Labs
         14.4.7.1. Overview
         14.4.7.2. Financials
         14.4.7.3. Developments
         14.4.7.4. Strategic Outlook
      14.4.8. Unimark Remedies
         14.4.8.1. Overview
         14.4.8.2. Financials
         14.4.8.3. Developments
         14.4.8.4. Strategic Outlook
      14.4.9. Jubilant Cadista
         14.4.9.1. Overview
         14.4.9.2. Financials
         14.4.9.3. Developments
         14.4.9.4. Strategic Outlook
      14.4.10. Aamorb Pharmaceuticals
         14.4.10.1. Overview
         14.4.10.2. Financials
         14.4.10.3. Developments
         14.4.10.4. Strategic Outlook
      14.4.11. Sudarshan Groups
         14.4.11.1. Overview
         14.4.11.2. Financials
         14.4.11.3. Developments
         14.4.11.4. Strategic Outlook
      14.4.12. Ortin Laboratories
         14.4.12.1. Overview
         14.4.12.2. Financials
         14.4.12.3. Developments
         14.4.12.4. Strategic Outlook
      14.4.13. Vamsi Labs
         14.4.13.1. Overview
         14.4.13.2. Financials
         14.4.13.3. Developments
         14.4.13.4. Strategic Outlook
      14.4.14. Adley Group
         14.4.14.1. Overview
         14.4.14.2. Financials
         14.4.14.3. Developments
         14.4.14.4. Strategic Outlook
      14.4.15. Medopharm
         14.4.15.1. Overview
         14.4.15.2. Financials
         14.4.15.3. Developments
         14.4.15.4. Strategic Outlook
      14.4.16. Hengyuan Pharmaceutical
         14.4.16.1. Overview
         14.4.16.2. Financials
         14.4.16.3. Developments
         14.4.16.4. Strategic Outlook
      14.4.17. Arromax Pharmaceutical Technology
         14.4.17.1. Overview
         14.4.17.2. Financials
         14.4.17.3. Developments
         14.4.17.4. Strategic Outlook
      14.4.18. Lihe Wuhan New Chemical Materials
         14.4.18.1. Overview
         14.4.18.2. Financials
         14.4.18.3. Developments
         14.4.18.4. Strategic Outlook
      14.4.19. Shanghai Huachu Chemical
         14.4.19.1. Overview
         14.4.19.2. Financials
         14.4.19.3. Developments
         14.4.19.4. Strategic Outlook
      14.4.20. COMPANY 20
         14.4.20.1. Overview
         14.4.20.2. Financials
         14.4.20.3. Developments
         14.4.20.4. Strategic Outlook

Our Trusted Clients

Contact Us